» Articles » PMID: 25990959

The Catalytic Activity of the Kinase ZAP-70 Mediates Basal Signaling and Negative Feedback of the T Cell Receptor Pathway

Overview
Journal Sci Signal
Date 2015 May 21
PMID 25990959
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

T cell activation by antigens binding to the T cell receptor (TCR) must be properly regulated to ensure normal T cell development and effective immune responses to pathogens and transformed cells while avoiding autoimmunity. The Src family kinase Lck and the Syk family kinase ZAP-70 (ζ chain-associated protein kinase of 70 kD) are sequentially activated in response to TCR engagement and serve as critical components of the TCR signaling machinery that leads to T cell activation. We performed a mass spectrometry-based phosphoproteomic study comparing the quantitative differences in the temporal dynamics of phosphorylation in stimulated and unstimulated T cells with or without inhibition of ZAP-70 catalytic activity. The data indicated that the kinase activity of ZAP-70 stimulates negative feedback pathways that target Lck and thereby modulate the phosphorylation patterns of the immunoreceptor tyrosine-based activation motifs (ITAMs) of the CD3 and ζ chain components of the TCR and of signaling molecules downstream of Lck, including ZAP-70. We developed a computational model that provides a mechanistic explanation for the experimental findings on ITAM phosphorylation in wild-type cells, ZAP-70-deficient cells, and cells with inhibited ZAP-70 catalytic activity. This model incorporated negative feedback regulation of Lck activity by the kinase activity of ZAP-70 and predicted the order in which tyrosines in the ITAMs of TCR ζ chains must be phosphorylated to be consistent with the experimental data.

Citing Articles

Advances in targeting protein S-palmitoylation in tumor immunity and therapy.

Han M, Lv Y, Chen Y, Li Z, Tian J, Zhou H Front Oncol. 2025; 15:1547636.

PMID: 40066091 PMC: 11891048. DOI: 10.3389/fonc.2025.1547636.


Tumor Microenvironment Drives the Cross-Talk Between Co-Stimulatory and Inhibitory Molecules in Tumor-Infiltrating Lymphocytes: Implications for Optimizing Immunotherapy Outcomes.

Franzese O Int J Mol Sci. 2024; 25(23).

PMID: 39684559 PMC: 11641238. DOI: 10.3390/ijms252312848.


The Role of the CD28 Family Receptors in T-Cell Immunomodulation.

Ciesielska-Figlon K, Lisowska K Int J Mol Sci. 2024; 25(2).

PMID: 38279272 PMC: 10816057. DOI: 10.3390/ijms25021274.


A Story of Kinases and Adaptors: The Role of Lck, ZAP-70 and LAT in Switch Panel Governing T-Cell Development and Activation.

Fernandez-Aguilar L, Vico-Barranco I, Arbulo-Echevarria M, Aguado E Biology (Basel). 2023; 12(9).

PMID: 37759563 PMC: 10525366. DOI: 10.3390/biology12091163.


INPP5E regulates CD3ζ enrichment at the immune synapse by phosphoinositide distribution control.

Chiu T, Lo C, Lin Y, Lai Y, Lin S, Fang Y Commun Biol. 2023; 6(1):911.

PMID: 37670137 PMC: 10480498. DOI: 10.1038/s42003-023-05269-0.


References
1.
Au-Yeung B, Levin S, Zhang C, Hsu L, Cheng D, Killeen N . A genetically selective inhibitor demonstrates a function for the kinase Zap70 in regulatory T cells independent of its catalytic activity. Nat Immunol. 2010; 11(12):1085-92. PMC: 3711183. DOI: 10.1038/ni.1955. View

2.
Schoenborn J, Tan Y, Zhang C, Shokat K, Weiss A . Feedback circuits monitor and adjust basal Lck-dependent events in T cell receptor signaling. Sci Signal. 2011; 4(190):ra59. PMC: 4080844. DOI: 10.1126/scisignal.2001893. View

3.
Markegard E, Trager E, Ou Yang C, Zhang W, Weiss A, Roose J . Basal LAT-diacylglycerol-RasGRP1 signals in T cells maintain TCRα gene expression. PLoS One. 2011; 6(9):e25540. PMC: 3180458. DOI: 10.1371/journal.pone.0025540. View

4.
Abel S, Roose J, Groves J, Weiss A, Chakraborty A . The membrane environment can promote or suppress bistability in cell signaling networks. J Phys Chem B. 2012; 116(11):3630-40. PMC: 3321252. DOI: 10.1021/jp2102385. View

5.
Dushek O, Goyette J, Anton van der Merwe P . Non-catalytic tyrosine-phosphorylated receptors. Immunol Rev. 2012; 250(1):258-76. DOI: 10.1111/imr.12008. View